Lumretuzumab

Modify Date: 2024-04-11 10:12:26

Use of Lumretuzumab

Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) is a humanized anti-HER3 monoclonal antibody that can be used for the research of cancer[1].

Name	Lumretuzumab

Description	Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) is a humanized anti-HER3 monoclonal antibody that can be used for the research of cancer[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR
Target	HER3
References	[1]. Schneeweiss A, et al. Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer. Invest New Drugs. 2018 Oct;36(5):848-859.

No Any Chemical & Physical Properties

Get all suppliers and price by the below link: